Stockreport

Bavarian Nordic's mpox vaccine to be trialled in pregnant women and infants [Yahoo! Finance]

BAVARIAN NORDIC R/I S/ADR  (BVNRY) 
NASDAQ:AMEX Investor Relations: bavarian-nordic.com/investor.aspx
PDF The Phase III trial (PregInPoxVac) will enrol around 350 pregnant women and 250 children aged two years and under to assess the safety and immunogenicity of the MVA-BN [Read more]